JERUSALEM, April 15, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced highlights from Dr. Rachel B ...
This study extends the literature that uses in HR pQCT to examine ''bone quality" in vivo in a novel way using customized image acquisition and analyses protocols to assess bone parameters in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results